First-line immune-checkpoint inhibitor plus chemotherapy <i>versus</i> chemotherapy alone for extensive-stage small-cell lung cancer: a meta-analysis

Abstract

First-line ICI+CT appears to be superior to CT alone for ES-SCLC except for patients with brain metastases at diagnosis.